Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Recent news and posts

Tags

Use tags to find relevant records
3D printed implants
Ablation methods
Allogeneic mesenchymal stem cells
Ambulatory ECG monitoring
Aortic abdominal aneurysm
Aortic root replacement
Arthroplasty
Arthroscopy
Assisted ventilation
Atherectomy
Austria
Autologous chondrocyte implantation
Automated external defibrillator
AV fistula
AV graft
Balloon kyphoplasty
Bariatric surgery
Baroreflex activation therapy
Barrett’s oesophagus
Belgium
Benign prostatic hyperplasia
Biopsy
Bone Conductive Hearing Device
Breast reconstruction
Bronchial thermoplasty
Burns
Caesarean section
Cancer
Capsule endoscopy
Carbon ion therapy
Cardiac ablation
Cardiac computer tomography
Cardiac pacemaker
Cardiac resynchronization therapy
Cardiac Resynchronization Therapy Defibrillator (CRT-D)
Cardiovascular devices
Cardiovascular procedures
Carotid endarterectomy
Cataract
Cell therapy
Cholecystectomy
Chronic obstructive pulmonary disease
Chronic wounds
Clinical guidelines
Cochlear implants
Commissioning
Computed tomography
Conditional reimbursement
Connected medical devices
Continuous glucose monitoring (CGM)
Coronary interventions
Coronary percutaneous revascularization procedures
Coronary procedures
Coronavirus
Coverage with evidence development (CED)
Critical care
See all tags

MTRC has released European reimbursement report for total and partial hip replacement in 11 EU countries

The report presents a summary of reimbursement situation for total and partial hip replacement in Europe. The following indications will be considered: coxarthrosis, osteonecrosis. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland.

Report was developed using an official reimbursement information. You can learn more and request sample pages at the report’s page.

It is possible to order analysis only for individual countries and add procedure volume data.

Contact us, if you would like to discuss the methodology and the content of the reports with our experts.

Tags
Hip replacement
Arthroplasty
MTRC Reimbursement Technology Report

The latest related news

26
Jun 2024

New procedure and diagnostic codes added to the private reimbursement schedule in England

On June 13, 2024, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclatures for private payers in England, published Bulletins 196 and 092 with changes to be implemented no later than August 8, 2024. Five new procedure codes related to endoscopy, ENT, orthopedics, and spine, as well as seven new diagnostic codes were introduced.
Read more
28
Dec 2023

New procedure codes in Finland from January 2024

On December 19, 2023, the updated Finnish classification of procedures (THL) was published to come into force on January 1, 2024. Thirty-two new procedure codes were implemented concerning cardiovascular, endoscopy, neurology, orthopedic, and other fields.
Read more
28
Jun 2023

Publications Digest: Reimbursement practices for use of digital devices in atrial fibrillation and other arrhythmias: a European Heart Rhythm Association survey

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Boriani et al. evaluated the expectations and opinions of healthcare professionals in Europe on reimbursement policies for the use of digital devices (including wearables) in atrial fibrillation and other arrhythmias. The study summarized information about the use of digital devices, trust in digital technologies, and availability of reimbursement of digital technologies in individual EU countries.

Read more
06
Jun 2023

Recommendations about add-on reimbursement for medical devices in France in May 2023

The French National Authority for Health (HAS) released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in May 2023. Twenty-one recommendations were published in relation to the registration, modification of registration conditions, and renewal of registration for devices in the List of reimbursable products and services (LPPR). Opinions concern cardiovascular and peripheral vascular, endocrine, ENT, gastrointestinal, and orthopedic devices, as well as medical aids.
Read more